DNA X, Inc. income statement SONM

Annual Quarterly

It recorded a net loss of $20.7 million. Diluted earnings per share were -$28.58. Over the twelve months ended Sep 30, 2025, revenue was $59.4 million and the net loss was $33.4 million. Across the 6 fiscal years shown, revenue shrank from $116.3 million in fiscal 2019 to $50.9 million in fiscal 2024, about 15.2% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line	FY 2025 Sep 30, 2025	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020	FY 2019 Dec 31, 2019
Revenue	59 +21.0%	—	51 -45.6%	94 +34.1%	70 +28.0%	55 -14.7%	64 -45.0%	116
Cost of revenue	48 +16.3%	—	48 -34.9%	74 +27.7%	58 +20.9%	48 -1.3%	49 -40.3%	82
Gross profit	11 -28.8%	—	10 -48.7%	19 +66.3%	12 +81.2%	6 -57.8%	15 -55.9%	35
Research and development	15 +473.9%	—	14 +703.3%	2 -77.8%	8 -54.9%	18 +9.1%	16 -37.8%	26
Selling, general and administrative	18 -19.9%	5 -66.3%	16 -5.7%	17 -5.0%	18 -9.6%	20 -2.0%	20 -30.2%	29
Operating income	-2 +87.2%	-5 -74.4%	-3 -704.3%	1 +103.6%	-14 +62.4%	-38 -29.9%	-29 -30.7%	-22
Pretax income	-3 +80.5%	-8 -175.9%	-3 -1115.1%	0 +102.0%	-14 +63.9%	-38 -26.3%	-30 -24.6%	-24
Income tax	0 -17.2%	-1 -607.1%	0 -39.6%	0 +103.3%	0 +10.2%	0 +132.1%	-1 -137.5%	1
Net income	-33 -149.4%	-21 +38.6%	-34 -37286.7%	-0 +99.4%	-14 +63.5%	-39 -29.0%	-30 -15.9%	-26
Basic EPS	-63.19 -516.3%	-28.58 +77.7%	-128.37 -641750.0%	-0.02 +95.9%	-0.49	—	—	—
Diluted EPS	-63.19 -471.7%	-28.58 +77.7%	-128.37 -641750.0%	-0.02	—	—	—	—
Weighted average shares, basic	1 -59.5%	1 +175.7%	0 -93.9%	4 -85.2%	29	—	—	—
Weighted average shares, diluted	1 -56.4%	1 +175.7%	0 -93.9%	4	—	—	—	—
Other measures
Depreciation and amortization	4 +3.3%	4 +20.9%	4 +61.2%	2 -7.1%	2 +11.6%	2 -22.0%	3 -22.6%	4
EBITDA	2 +122.7%	-1 -342.0%	0 -83.2%	3 +122.8%	-12 +66.8%	-36 -35.2%	-27 -40.7%	-19
Interest coverage	—	-5.72x	—	—	-147.32x	—	—	—
Margins
Gross margin	18.24%	—	19.48%	20.64%	16.65%	11.75%	23.77%	29.68%
Operating margin	-2.75%	—	-6.09%	0.55%	-20.46%	-69.64%	-45.72%	-19.25%
Pretax margin	-4.27%	—	-5.66%	0.30%	-19.91%	-70.48%	-47.59%	-21.03%
Profit margin	-56.21%	—	-66.08%	-0.10%	-20.17%	-70.78%	-46.77%	-22.22%
EBITDA margin	3.51%	—	0.90%	2.90%	-17.06%	-65.74%	-41.46%	-16.22%
Effective tax rate	—	—	—	131.69%	—	—	—	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Telephone & Telegraph Apparatus (SIC 3661)
Listed as: SONM (Nasdaq)
Fiscal year ends: December 31
Incorporated in: DE
Headquarters: San Diego, CA
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 1178697
Former names: SONIM TECHNOLOGIES INC (until Jan 23, 2026)

Other Telephone & Telegraph Apparatus companies

All 9 Telephone & Telegraph Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.